Drug Database
N05AX13 paliperidone
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Byannli 1000 mg prolonged-release suspension for injection in pre-filled syringe
- POM Byannli 700 mg prolonged-release suspension for injection in pre-filled syringe
- POM Invega 3 mg prolonged-release tablets
- POM Invega 6 mg prolonged release tablets
- POM Invega 9 mg prolonged-release tablets
- POM Paliperidone Mercury Pharma 100 mg prolonged-release suspension for injection in pre-filled syringe
- POM Paliperidone Mercury Pharma 150 mg prolonged-release suspension for injection in pre-filled syringe
- POM Paliperidone Mercury Pharma 25 mg prolonged-release suspension for injection in pre-filled syringe
- POM Paliperidone Mercury Pharma 50 mg prolonged-release suspension for injection in pre-filled syringe
- POM Paliperidone Mercury Pharma 75 mg prolonged-release suspension for injection in pre-filled syringe
- POM TREVICTA 175mg prolonged release suspension for injection
- POM TREVICTA 263mg prolonged release suspension for injection
- POM TREVICTA 350mg prolonged release suspension for injection
- POM TREVICTA 525mg prolonged release suspension for injection
- POM XEPLION 100 mg prolonged release suspension for injection
- POM XEPLION 150 mg prolonged release suspension for injection
- POM XEPLION 50 mg prolonged release suspension for injection
- POM XEPLION 75 mg prolonged release suspension for injection
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).